Enterprise Leadership Team
Robert Stone, president and chief executive officer, and the talented individuals below are leading City of Hope toward the next horizon of treatments and cures for life-threatening diseases.
Robert Stone is president and award-winning chief executive officer at the helm of City of Hope’s rapid evolution into a world leader in cancer research, treatment and prevention. Under his strategic and visionary direction, City of Hope is accelerating opportunities for high-impact discovery and
Kristin Bertell is the chief philanthropy officer at City of Hope, a Charity Navigator four-star-rated organization, who provides strategic leadership for all of its philanthropic efforts, executing a diverse portfolio of fundraising programs and activities.
William D. Boswell Jr., M.D., chair of the Department of Diagnostic Radiology, is an authority in urologic cancers, hematologic malignancies, oncologic imaging, telemedicine and telehealth at City of Hope, as well as a health care leader for Los Angeles County.
Michael A. Caligiuri, M.D., president of City of Hope National Medical Center, is a world-renowned physician, scientist, builder, innovator, leader and visionary. He is dedicated to developing the next generation of leading-edge cancer therapies.
Kety Duron, chief human resources officer, provides executive strategy and oversight for City of Hope’s human resources initiatives.
Debra Fields, executive vice president and chief transformation officer, leads the teams focused on accelerating City of Hope’s impact through aligned organizational governance and design, progressive talent strategy, change navigation and integration methodology, and marketing and communications
David Horne, Ph.D., vice provost and deputy director of Beckman Research Institute of City of Hope and dean of faculty affairs, helps shape the scientific and educational vision of City of Hope with his research expertise in medicinal chemistry, drug development and molecular medicine.
Mark Hulse, chief digital officer at City of Hope, is responsible for fostering a digital transformation culture and leading digital solution development across the organization.
Vince Jensen, M.B.A., serves City of Hope as Chief Clinical Operating Officer, where he leads City of Hope's expansive clinical services on campus and within its clinical network. He also serves as chief executive for City of Hope Medical Foundation, City of Hope’s faculty practice plan and
Harlan Levine, M.D., is president of strategy and business ventures for City of Hope. In this role, he is accountable for strategy, innovation and growth, drug commercialization, payer strategies and the Center for International Medicine.
Gulden Mesara, M.B.A., is senior vice president and chief communications and marketing officer at City of Hope. She provides overall strategic leadership for all marketing and communications initiatives, as the premier cancer treatment and biomedical research center enters another era of growth and
Cristin O’Callahan is City of Hope’s General Counsel and Corporate Secretary, overseeing the departments responsible for legal matters, risk mitigation and ethics and compliance as well as serving as corporate secretary.
Jennifer Parkhurst, chief financial officer at City of Hope, leads all financial functions and provides strategic guidance to the organization.
Lorna Rodriguez-Rodriguez, M.D., Ph.D., is eagerly continuing her ovarian cancer investigations at City of Hope, which she calls “the perfect environment” that's home to “many amazing scientists and clinicians (with) similar goals about making discoveries to cure cancer.”
Steven T. Rosen, M.D., provost and chief scientific officer, and director of the comprehensive cancer center and Beckman Research Institute of City of Hope, sets the scientific direction of City of Hope, shaping its vision as a cancer research, treatment and educational institution.
Eileen P. Smith, M.D., chair of the Department of Hematology & Hematopoietic Cell Transplantation, leads City of Hope with her expertise in hematology and oncology.
Angela L. Talton leads the development of a new vision and strategy to advance diversity, equity and inclusion at City of Hope, continuing its holistic and integrated focus to build a diverse and inclusive culture at all levels of the enterprise.
Jeffrey M. Trent, Ph.D., is the president and research director of Translational Genomics Research Institute (TGen), which joined forces with City of Hope to accelerate the speed at which scientists and medical staff convert research discoveries into cures for patients.
Vijay Trisal, M.D., the Dr. Norman & Melinda Payson Professor in Medicine and chief medical officer at City of Hope, is an advocate for individualized patient care and expanding access to City of Hope’s advanced therapies and specialized physicians across local communities.
Annette Walker, president of City of Hope, Orange County, drives the development and growth of a 21st-century comprehensive cancer campus in Irvine and a network of care that will provide Orange County residents unprecedented access to leading-edge medicine.